Price Alert

Ekso Bionics Inc. (EKSO)

NASDAQ: EKSO · Real-Time Price · USD

5.60

0.28 (5.26%)

At close: Oct 03, 2025, 3:59 PM

5.56

-0.72%

After-hours: Oct 03, 2025, 07:07 PM EDT

5.26% (1D)

Bid	5.52
Market Cap	14.63M
Revenue (ttm)	14.65M
Net Income (ttm)	-11.09M
EPS (ttm)	-6.49
PE Ratio (ttm)	-0.86
Forward PE	-6.49
Analyst	Buy
Dividends	n/a

Ask	5.7
Volume	61,923
Avg. Volume (20D)	82,095
Open	5.55
Previous Close	5.32
Day's Range	5.53 - 5.67
52-Week Range	2.73 - 17.32
Beta	1.11
Ex-Dividend Date	n/a

About EKSO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol EKSO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for EKSO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Ekso Bionics Inc. is scheduled to release its earnings on Oct 27, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-27.37%

EKSO Bionics shares are trading lower after the co... Unlock content with Pro Subscription

4 months ago

+10.29%

Ekso Bionics shares are trading higher after the company announced it will reschedule its reverse stock split.

News

1 week ago · zacks.com

Ekso Bionics (EKSO) Upgraded to Buy: Here's What You Should Know

Ekso Bionics (EKSO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 month ago · zacks.com

Ekso Bionics (EKSO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among W...

2 months ago · seekingalpha.com

Ekso Bionics Holdings, Inc. (EKSO) Q2 2025 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q2 2025 Earnings Conference Call July 28, 2025 4:30 PM ET Company Participants Jerome Wong - CFO & Corporate Secretary Scott G. Davis - CEO & Director Stephe...

2 months ago · zacks.com

Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates

Ekso Bionics (EKSO) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $1.2. This compares to a loss of $1.95 per share a year ago.

2 months ago · fool.com

Ekso Revenue Falls 58 Percent in Q2